These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16004377)

  • 1. Antimicrosporidial activity of (fluoro)quinolones in vitro and in vivo.
    Didier ES; Bowers L; Stovall ME; Kuebler D; Mittleider D; Brindley PJ; Didier PJ
    Folia Parasitol (Praha); 2005 May; 52(1-2):173-81. PubMed ID: 16004377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrosporidial activities of fumagillin, TNP-470, ovalicin, and ovalicin derivatives in vitro and in vivo.
    Didier PJ; Phillips JN; Kuebler DJ; Nasr M; Brindley PJ; Stovall ME; Bowers LC; Didier ES
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2146-55. PubMed ID: 16723577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsporidiosis: an emerging and opportunistic infection in humans and animals.
    Didier ES
    Acta Trop; 2005 Apr; 94(1):61-76. PubMed ID: 15777637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of compounds for antimicrosporidial activity in vitro.
    Didier ES; Maddry JA; Kwong CD; Green LC; Snowden KF; Shadduck JA
    Folia Parasitol (Praha); 1998; 45(2):129-39. PubMed ID: 9684323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of albendazole, fumagillin, and TNP-470 on microsporidial replication in vitro.
    Didier ES
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1541-6. PubMed ID: 9210681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence survey of the genome of the opportunistic microsporidian pathogen, Vittaforma corneae.
    Mittleider D; Green LC; Mann VH; Michael SF; Didier ES; Brindley PJ
    J Eukaryot Microbiol; 2002; 49(5):393-401. PubMed ID: 12425527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic strategies for human microsporidia infections.
    Didier ES; Maddry JA; Brindley PJ; Stovall ME; Didier PJ
    Expert Rev Anti Infect Ther; 2005 Jun; 3(3):419-34. PubMed ID: 15954858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of microsporidiosis including albendazole.
    Gross U
    Parasitol Res; 2003 Jun; 90 Supp 1():S14-8. PubMed ID: 12811545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsporidiosis: epidemiology, clinical data and therapy.
    Anane S; Attouchi H
    Gastroenterol Clin Biol; 2010 Sep; 34(8-9):450-64. PubMed ID: 20702053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigations into microsporidian methionine aminopeptidase type 2: a therapeutic target for microsporidiosis.
    Zhang H; Huang H; Cali A; Takvorian PM; Feng X; Zhou G; Weiss LM
    Folia Parasitol (Praha); 2005 May; 52(1-2):182-92. PubMed ID: 16004378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNP-470 is an effective antimicrosporidial agent.
    Coyle C; Kent M; Tanowitz HB; Wittner M; Weiss LM
    J Infect Dis; 1998 Feb; 177(2):515-8. PubMed ID: 9466552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of microsporidiosis: sources and modes of transmission.
    Didier ES; Stovall ME; Green LC; Brindley PJ; Sestak K; Didier PJ
    Vet Parasitol; 2004 Dec; 126(1-2):145-66. PubMed ID: 15567583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular surveillance of Vittaforma-like microsporidia by a small-volume procedure in drinking water source in Taiwan: evidence for diverse and emergent pathogens.
    Chen JS; Hsu BM; Tsai HC; Chen YP; Huang TY; Li KY; Ji DD; Lee HS
    Environ Sci Pollut Res Int; 2018 Jul; 25(19):18823-18837. PubMed ID: 29713979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro culture of various species of microsporidia causing keratitis: evaluation of three immortalized cell lines.
    Joseph J; Sharma S
    Indian J Med Microbiol; 2009; 27(1):35-9. PubMed ID: 19172057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-targeting properties of the 3-aminopyrrolidyl quinolones, DC-159a and sitafloxacin, against DNA gyrase and topoisomerase IV: contribution to reducing in vitro emergence of quinolone-resistant Streptococcus pneumoniae.
    Okumura R; Hirata T; Onodera Y; Hoshino K; Otani T; Yamamoto T
    J Antimicrob Chemother; 2008 Jul; 62(1):98-104. PubMed ID: 18390884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encephalitozoon cuniculi and Vittaforma corneae (Phylum Microsporidia) inhibit staurosporine-induced apoptosis in human THP-1 macrophages in vitro.
    Sokolova YY; Bowers LC; Alvarez X; Didier ES
    Parasitology; 2019 Apr; 146(5):569-579. PubMed ID: 30486909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of fluoroquinolones against Mycobacterium tuberculosis.
    Sulochana S; Rahman F; Paramasivan CN
    J Chemother; 2005 Apr; 17(2):169-73. PubMed ID: 15920901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single- and multi-step resistance selection study of gemifloxacin compared with trovafloxacin, ciprofloxacin, gatifloxacin and moxifloxacin in Streptococcus pneumoniae.
    Nagai K; Davies TA; Dewasse BE; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 2001 Sep; 48(3):365-74. PubMed ID: 11533001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of aminopeptidase activity from three species of microsporidia: Encephalitozoon cuniculi, Encephalitozoon hellem, and Vittaforma corneae.
    Millership JJ; Chappell C; Okhuysen PC; Snowden KF
    J Parasitol; 2002 Oct; 88(5):843-8. PubMed ID: 12435118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
    Turner AK; Nair S; Wain J
    J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.